Stephen Galli
Directeur/Membre du Conseil chez ATOSSA THERAPEUTICS, INC.
Fortune : 150 $ au 30/04/2024
Postes actifs de Stephen Galli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2011 | - |
| Independent Dir/Board Member | 01/07/2011 | - | |
| Stanford University School of Medicine | Corporate Officer/Principal | 01/02/1999 | - |
| Association of Pathology Chairs | President | - | - |
Historique de carrière de Stephen Galli
Anciens postes connus de Stephen Galli
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Collegium Internationale Allergologicum | President | 06/10/2010 | - |
American Society for Investigative Pathology
 American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | President | - | - |
Formation de Stephen Galli
| Harvard College | Undergraduate Degree |
| Harvard Medical School | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 8 |
Opérationnelle
| President | 3 |
| Director/Board Member | 1 |
| Independent Dir/Board Member | 1 |
Sectorielle
| Consumer Services | 4 |
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ATOSSA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
American Society for Investigative Pathology
American Society for Investigative Pathology BiotechnologyHealth Technology The American Society for Investigative Pathology operates as a biotechnology company. | Health Technology |
| Collegium Internationale Allergologicum | |
| Association of Pathology Chairs |
- Bourse
- Insiders
- Stephen Galli
- Expérience
